The validations confirm the completion of the applications and commence the scientific review process
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The facility will accommodate over 1,500 employees
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
The initiative, “Change the Odds: Uniting to Improve Cancer Outcomes” aims to enhance awareness of and access to cancer screening, clinical trials and support
Subscribe To Our Newsletter & Stay Updated
